Oregon Public Employees Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,819	Closed	-$1.21M	–	1548
2023 Q3	$1.21M	Sell	6,819 -3,309	-33%	-$631K	0.02%	847
2023 Q2	$1.92M	Sell	10,128 -10,100	-50%	-$2M	0.02%	642
2023 Q1	$4.05M	Buy	20,228 +208	+1%	+$43.7K	0.05%	351
2022 Q4	$4.76M	Buy	+20,020	New	+$4.27M	0.06%	318
2020 Q4	–	Sell	-15,500	Closed	-$2.26M	–	1604
2020 Q3	$2.26M	Sell	15,500 -800	-5%	-$114K	0.03%	425
2020 Q2	$2.41M	Sell	16,300 -8,800	-35%	-$1.19M	0.04%	407
2020 Q1	$2.73M	Buy	+25,100	New	+$2.9M	0.05%	332
2018 Q2	–	Sell	-18,002	Closed	-$2.14M	–	1094
2018 Q1	$2.14M	Buy	18,002 +79	+0.4%	+$10.2K	0.03%	568
2017 Q4	$2.28M	Buy	+17,923	New	+$2.25M	0.03%	541
2016 Q3	–	Sell	-100	Closed	-$6K	–	927
2016 Q2	$6K	Hold	100	–	–	﹤0.01%	1021
2016 Q1	$6K	Hold	100	–	–	﹤0.01%	1017
2015 Q4	$9K	Hold	100	–	–	﹤0.01%	1022
2015 Q3	$8K	Hold	100	–	–	﹤0.01%	1022
2015 Q2	$12K	Buy	+100	New	+$11.9K	﹤0.01%	1025

Other funds holding ALNY

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ALNY Position: Q4 2023 in Review

Oregon Public Employees Retirement Fund sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2023, closing a stake of 6,819 shares — an estimated $1.21M sold.

Oregon Public Employees Retirement Fund first reported a position in ALNY in Q2 2015 and held it in 14 quarters. The position peaked at $4.76M in Q4 2022. 499 funds tracked by Wall St. Rank hold ALNY as of Q4 2023.

Oregon Public Employees Retirement Fund reported no remaining Alnylam Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 6,819 Alnylam Pharmaceuticals shares in Q4 2023, an estimated $1.21M.
Oregon Public Employees Retirement Fund first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 14 quarters.
Oregon Public Employees Retirement Fund's Alnylam Pharmaceuticals position peaked at $4.76M in Q4 2022.
499 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q4 2023, filed 12 Feb 2024.